HCC: The role of immunotherapy beyond advanced HCC

December 06, 2023 00:29:42
HCC: The role of immunotherapy beyond advanced HCC
COR2ED - Oncology Medical Conversation
HCC: The role of immunotherapy beyond advanced HCC

Dec 06 2023 | 00:29:42

/

Show Notes

In this podcast, liver cancer experts Prof. Amit Singal and Assoc. Prof Neil Mehta discuss recent advances in systemic and locoregional therapy for advanced and early stage hepatocellular carcinoma (HCC).  They focus on the role of immunotherapy and review data from three major congresses in 2022 (ASCO, WCGIC and ILC) together with recent publications. 

Prof. Amit Singal is Director of Liver Cancer Program at UT Southwestern Medical Center, Dallas, TX, USA and Assoc. Prof. Neil Mehta is Director of Liver Cancer Program at University of California San Francisco, USA.

Other Episodes

Episode

December 06, 2023 00:27:14
Episode Cover

Sarcoma: Updated bone sarcoma guidelines - Clinical implications

In this SARCOMA CONNECT Guidelines Podcast, two SARCOMA CONNECT Experts, Prof. Robert Maki and Prof. Silvia Stacchiotti, discuss recent updates in the ESMO and...

Listen

Episode

January 25, 2024 00:27:48
Episode Cover

Lung cancer: Pre-analytical phase challenges and biomarker testing

What are the common pre-analytical phase challenges in lung cancer, and how can we overcome them? Why is it important to identify genetic alterations?...

Listen

Episode

December 06, 2023 00:29:56
Episode Cover

HCC: VEGFR-TKIs alone or in combination with immune checkpoint inhibitors

In this medical education podcast episode, Prof. Peter Galle and Prof. Amit Singal discuss the use of VEGFR-TKIs in the treatment of advanced or...

Listen